New 12-Week therapy aims to tackle trauma and addiction together

NCT ID NCT07193914

Recruiting now Symptom relief Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 12-week group therapy program called ECCCLORE for people who have both post-traumatic stress disorder (PTSD) and addiction. The program combines skills for managing emotions, distress, and relationships. Researchers want to see if it is feasible and acceptable for patients. 30 adults will participate, attending weekly group sessions plus short individual check-ins.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ECCCLORE program (cognitive behavioral therapy group sessions)
What this could lead to: If successful, this could provide a shorter, group-based therapy option that helps people manage both trauma and addiction together.
What could go wrong: This is a very small, early feasibility study with only 30 participants, so results may not apply widely. The program may not be acceptable or practical for many patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADDICTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior, Addictive post-traumatic stress disorder substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADDICTION CBT PTSD SUBSTANCE USE DISORDERS

Contacts and locations

Locations

CHU de Nîmes
RECRUITING

Nîmes, Nîmes, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.